SynCore Biotechnology (Taiwan) Analysis
| 4192 Stock | TWD 34.00 0.10 0.29% |
SynCore Biotechnology Co is overvalued with Real Value of 29.34 and Hype Value of 34.0. The main objective of SynCore Biotechnology stock analysis is to determine its intrinsic value, which is an estimate of what SynCore Biotechnology Co is worth, separate from its market price. There are two main types of SynCore Biotechnology's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect SynCore Biotechnology's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of SynCore Biotechnology's stock to identify patterns and trends that may indicate its future price movements.
The SynCore Biotechnology stock is traded in Taiwan on Taiwan OTC Exchange, with the market opening at 09:00:00 and closing at 13:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Taiwan. SynCore Biotechnology is usually not traded on Chinese New Year, Dragon Boat Festival, National Day of the Republic of China, Chinese New Year 2, Chinese New Year 3, Adjusted Holiday 1, Adjusted Holiday 2, Mid - autumn / Moon Festival. SynCore Stock trading window is adjusted to Asia/Taipei timezone.
SynCore |
SynCore Stock Analysis Notes
About 67.0% of the company shares are owned by insiders or employees . The company recorded a loss per share of 3.73. SynCore Biotechnology had not issued any dividends in recent years. The entity had 1000:267 split on the 26th of June 2023. ,Ltd, a biopharmaceutical company, engages in the research and development, manufacture, and marketing of drugs in the areas of oncology, ophthalmology, dermatology, and infectious diseases in Taiwan and internationally. The company was founded in 2008 and is headquartered in Yilan, Taiwan. SYNCORE BIOTECHNOL operates under Biotechnology classification in Taiwan and is traded on Taiwan OTC Exchange. It employs 81 people. For more info on SynCore Biotechnology Co please contact the company at 886 3 958 6101 or go to https://www.syncorebio.com.SynCore Biotechnology Investment Alerts
| The company reported the revenue of 6.94 M. Net Loss for the year was (458.6 M) with profit before overhead, payroll, taxes, and interest of 2.97 M. | |
| SynCore Biotechnology Co has accumulated about 380.81 M in cash with (229.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.57. | |
| Roughly 67.0% of the company shares are owned by insiders or employees |
SynCore Biotechnology Thematic Classifications
In addition to having SynCore Biotechnology stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | BiotechBiotechnology and pharmaceuticals production and services |
SynCore Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.88 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate SynCore Biotechnology's market, we take the total number of its shares issued and multiply it by SynCore Biotechnology's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 27th of March, SynCore Biotechnology has the Variance of 10.75, risk adjusted performance of 0.0032, and Coefficient Of Variation of (19,948). SynCore Biotechnology technical analysis provides you with a way to harness past market data to determine a pattern that measures the direction of the company's future prices. Please validate SynCore Biotechnology standard deviation, information ratio, maximum drawdown, as well as the relationship between the variance and treynor ratio to decide if SynCore Biotechnology is priced more or less accurately, providing market reflects its prevalent price of 34.0 per share.SynCore Biotechnology Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. SynCore Biotechnology middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for SynCore Biotechnology. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
SynCore Biotechnology Outstanding Bonds
SynCore Biotechnology issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. SynCore Biotechnology uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most SynCore bonds can be classified according to their maturity, which is the date when SynCore Biotechnology Co has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
SynCore Biotechnology Predictive Daily Indicators
SynCore Biotechnology intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of SynCore Biotechnology stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 34.0 | |||
| Day Typical Price | 34.0 | |||
| Price Action Indicator | 0.05 | |||
| Period Momentum Indicator | 0.1 | |||
| Relative Strength Index | 45.16 |
SynCore Biotechnology Forecast Models
SynCore Biotechnology's time-series forecasting models are one of many SynCore Biotechnology's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary SynCore Biotechnology's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About SynCore Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how SynCore Biotechnology prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling SynCore shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as SynCore Biotechnology. By using and applying SynCore Stock analysis, traders can create a robust methodology for identifying SynCore entry and exit points for their positions.
,Ltd, a biopharmaceutical company, engages in the research and development, manufacture, and marketing of drugs in the areas of oncology, ophthalmology, dermatology, and infectious diseases in Taiwan and internationally. The company was founded in 2008 and is headquartered in Yilan, Taiwan. SYNCORE BIOTECHNOL operates under Biotechnology classification in Taiwan and is traded on Taiwan OTC Exchange. It employs 81 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding SynCore Biotechnology to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Commodity Channel Now
Commodity ChannelUse Commodity Channel Index to analyze current equity momentum |
| All Next | Launch Module |
Additional Tools for SynCore Stock Analysis
When running SynCore Biotechnology's price analysis, check to measure SynCore Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SynCore Biotechnology is operating at the current time. Most of SynCore Biotechnology's value examination focuses on studying past and present price action to predict the probability of SynCore Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SynCore Biotechnology's price. Additionally, you may evaluate how the addition of SynCore Biotechnology to your portfolios can decrease your overall portfolio volatility.